{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:08:41Z","timestamp":1789402121386,"version":"build-2803163510"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07960-w","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T03:26:34Z","timestamp":1789356394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Apixaban Versus LMWH in CAT\/VTE: A Comment on Clinical and Methodological Heterogeneity"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5111-2216","authenticated-orcid":false,"given":"Chenchen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"7960_CR1","doi-asserted-by":"publisher","unstructured":"Huang C, Li S, He J. Apixaban versus low-molecular-weight heparin in cancer-associated thrombosis: An indication-stratified systematic review and meta-analysis of treatment and postoperative prophylaxis. Cardiovasc Drugs Ther Published online August. 2026;20. https:\/\/doi.org\/10.1007\/s10557-026-07908-0.","DOI":"10.1007\/s10557-026-07908-0"},{"key":"7960_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ygyno.2024.01.039","volume":"183","author":"A Knisely","year":"2024","unstructured":"Knisely A, Iniesta MD, Batman S, et al. Efficacy, safety, and feasibility of Apixaban for postoperative venous thromboembolism prophylaxis following open gynecologic cancer surgery at a comprehensive cancer center. Gynecol Oncol. 2024;183:120\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2024.01.039.","journal-title":"Gynecol Oncol"},{"issue":"8","key":"7960_CR3","doi-asserted-by":"publisher","first-page":"103244","DOI":"10.1016\/j.rpth.2025.103244","volume":"9","author":"M Monreal","year":"2025","unstructured":"Monreal M, Brenner B, G\u00f3mez-Cuervo C, et al. Comparative safety of enoxaparin versus other low-molecular-weight heparins in cancer-associated venous thromboembolism: A real-world cohort study from RIETE. Res Pract Thromb Haemost. 2025;9(8):103244. https:\/\/doi.org\/10.1016\/j.rpth.2025.103244. Published 2025 Oct 31.","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"7960_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/1475-6773.13697","volume":"56","author":"CE Fry","year":"2021","unstructured":"Fry CE, Hatfield LA. Birds of a feather flock together: Comparing controlled pre-post designs. Health Serv Res. 2021;56(5):942\u201352. https:\/\/doi.org\/10.1111\/1475-6773.13697.","journal-title":"Health Serv Res"},{"issue":"14","key":"7960_CR5","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","volume":"392","author":"I Mah\u00e9","year":"2025","unstructured":"Mah\u00e9 I, Carrier M, Mayeur D, et al. Extended reduced-dose apixaban for cancer-associated venous thromboembolism. N Engl J Med. 2025;392(14):1363\u201373. https:\/\/doi.org\/10.1056\/NEJMoa2416112.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07960-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:01:37Z","timestamp":1789401697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07960-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":5,"alternative-id":["7960"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07960-w","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"7 September 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}